ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,953Medicare Part D Prescriptions Filled, Including Refills

Rank: 117 out of 5176

$1.74M Total Retail Price of All Prescriptions

Rank: 78 out of 5176

375 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 375 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 18,105 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

59% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$92 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
CRESTOR 1,631 1,559 1 15
NEXIUM 670 647 2 16
LOVAZA 519 508 3 43
METOPROLOL TARTRATE 513 489 4 6
ZOLPIDEM TARTRATE 479 452 5 17
AMLODIPINE BESYLATE 409 389 6 2
BYSTOLIC 396 388 7 96
PLAVIX 368 355 8 29
METOPROLOL SUCCINATE 352 337 9 11
LOSARTAN POTASSIUM 348 320 10 14
ATELVIA 315 308 11 146
CARVEDILOL 295 290 12 24
CLOPIDOGREL 292 274 13 26
SYNTHROID 288 288 14 33
BENICAR HCT 270 267 15 110
LOSARTAN-HYDROCHLOROTHIAZIDE 270 243 15 35
OMEPRAZOLE 266 231 17 3
RANEXA 261 248 18 167
MICARDIS HCT 249 249 10 19 180
FUROSEMIDE 244 231 20 8
METFORMIN HCL 238 238 21 7
DIOVAN 223 219 22 19
TAMSULOSIN HCL 222 222 23 20
ISOSORBIDE MONONITRATE ER 214 210 24 44
GLIMEPIRIDE 211 199 25 37
ALLOPURINOL 209 185 26 41
ATENOLOL 203 203 27 12
DIOVAN HCT 193 168 28 39
JANUMET 191 162 29 77
LIDODERM 191 189 29 59
LEVOTHYROXINE SODIUM 186 183 31 4
CLONIDINE HCL 152 150 32 79
COUMADIN 149 148 33 112
JANUVIA 146 135 34 25
SIMVASTATIN 145 145 35 1
WARFARIN SODIUM 142 141 36 13
NAMENDA 141 141 37 47
CREON 126 115 38 111
SPIRIVA 124 115 39 54
MECLIZINE HCL 123 123 40 81
LANSOPRAZOLE 117 102 41 113
ENALAPRIL MALEATE 115 94 42 22
NITROGLYCERIN PATCH 111 111 43 149
CELEBREX 108 108 44 80
KOMBIGLYZE XR 106 104 45 291
RAMIPRIL 103 97 46 50
AMITIZA 103 103 46 197
MICARDIS 103 103 46 154
ONGLYZA 98 98 49 153
TRILIPIX 97 86 50 187
DEXILANT 97 95 50 118
DONEPEZIL HCL 96 96 52 28
MELOXICAM 95 94 53 53
RANITIDINE HCL 92 92 54 36
EVISTA 91 91 55 65
AZITHROMYCIN 90 79 56 42
DIGOXIN 89 81 57 56
GABAPENTIN 88 84 58 21
LISINOPRIL 87 73 59 5
EXFORGE 82 82 60 126
VOLTAREN 80 79 61 97
FINASTERIDE 78 78 62 69
ATORVASTATIN CALCIUM 77 70 63 9
ACTOPLUS MET 77 77 63 268
SPIRONOLACTONE 75 67 65 88
PROCTOZONE-HC 73 73 66 171
AVODART 71 71 67 107
BENICAR 71 71 67 100
ADVAIR DISKUS 71 69 67 32
HYDRALAZINE HCL 70 70 70 73
PROAIR HFA 69 68 71 60
LYRICA 68 68 72 133
CLOBETASOL PROPIONATE 65 65 73 130
LIPITOR 63 60 74 51
AMLODIPINE BESYLATE-BENAZEPRIL 62 54 75 55
PRANDIN 62 59 75 150
COLCRYS 61 61 77 170
HYDROCHLOROTHIAZIDE 61 60 77 10
ESCITALOPRAM OXALATE 56 56 79 89
PRAVASTATIN SODIUM 56 53 79 23
TRAMADOL HCL 55 53 81 40
VESICARE 53 44 82 210
SYMBICORT 52 52 83 120
ENABLEX 52 52 83 284
ZETIA 51 46 85 68
POTASSIUM CHLORIDE 50 47 86 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.